Two recent scientific papers about optimal treatment of older patients with cancer not only improve clinical care but also demonstrate Wilmot Cancer Institute's international leadership in this growing field.
Sep 4, 2024
0
0
While immune checkpoint inhibitors (ICIs) can provide lifesaving treatment for patients with cancer, they have also been found to cause immune-related adverse events (irAEs)—side effects that can impact almost every organ ...
Sep 4, 2024
0
1
Researchers at the University of Kentucky are testing the effectiveness of a vaccine that may be able to treat pancreatic cancer.
Sep 4, 2024
0
1
A new study from researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) sheds light on why certain oligodendrocyte progenitor cells (OPCs) in the adult brain transform into gliomas, ...
Sep 3, 2024
0
19
Led by investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Experimental Therapeutics Group, in collaboration with VHIO's Hereditary Cancer Genetics Group and the Medical Oncology Department at the Vall d'Hebron ...
Sep 3, 2024
0
1
For many doctors and researchers, immunotherapy that uses someone's own immune system to target and attack cancer cells is the next and best frontier of cancer treatment. Chimeric antigen receptor T-cell therapy, or CAR-T ...
Sep 3, 2024
0
1
Prostate cancer is the second most common cancer among men worldwide, following lung cancer. In the United States alone, nearly 300,000 new cases are diagnosed annually. While reducing testosterone and other male hormones ...
Sep 3, 2024
0
0
In patients with newly diagnosed type 2 diabetes, baseline interleukin-6 (IL-6) levels may enhance prediction of new-onset obesity-related cancers, according to a study scheduled to be presented at the annual meeting of the ...
Sep 3, 2024
0
0
Researchers from QIMR Berghofer have found that declining melanoma rates among young Australians have been influenced by the country's increasingly diverse population and more varied skin tones.
Sep 3, 2024
0
0
Researchers at WEHI have identified a promising new two-in-one treatment that not only targets and destroys an aggressive form of brain cancer, but also helps the immune system develop a lasting defense against it.
Sep 2, 2024
0
17
